Senti bio awarded california institute for regenerative medicines (cirm) grant for clinical development of logic gated car-nk cell therapy

South san francisco, calif., july 01, 2024 (globe newswire) -- senti biosciences, inc. (nasdaq: snti) (“senti bio”), a biotechnology company developing next-generation cell and gene therapies using its proprietary gene circuit platform, today announced that the california institute for regenerative medicines (“cirm”) has awarded an $8 million grant to senti bio.
CAR Ratings Summary
CAR Quant Ranking